Skip to content
lifestyle.celebhomes.net
Author:
ABLi Therapeutics
ABLi Therapeutics Announces Outcomes from its Parkinson’s-related Biomarker Study Demonstrating Modification of Human Disease with Risvodetinib
August 4, 2026